Integrins in Pulmonary Inflammatory Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|7|893-901

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.7, 2005-03, pp. : 893-901

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases

By Fox A.J.   Patel H.J.   Barnes P.J.   Belvisi M.G.  

European Journal of Pharmacology, Vol. 424, Iss. 2, 2001-07 ,pp. : 159-162

Elsevier

Access to resources Recommend Favorite

Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases

By Chopra Puneet   Kanoje Vijay   Semwal Arvind   Ray Abhijit  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1411-1425

Informa Healthcare

Access to resources Recommend Favorite

Adhesion Molecules in Inflammatory Diseases

By González-Amaro R.  

Drugs, Vol. 56, Iss. 6, 1998-12 ,pp. : 977-988

Adis International

Access to resources Recommend Favorite

Keratinocytes in Inflammatory Skin Diseases

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 329-334

Bentham Science Publishers

Access to resources Recommend Favorite

HLA-G and Inflammatory Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 2, 2008-06 ,pp. : 67-74

Bentham Science Publishers

Access to resources Recommend Favorite